scholarly journals Bap1 and Pbrm1: Determinants of Tumor Grade and mTOR Activation in VHL-Deficient Mouse Models of Renal Cell Carcinoma

2017 ◽  
Vol 7 (8) ◽  
pp. 802-804 ◽  
Author(s):  
Janet Y. Leung ◽  
William Y. Kim
Author(s):  
Zahra Khodabakhshi ◽  
Mehdi Amini ◽  
Shayan Mostafaei ◽  
Atlas Haddadi Avval ◽  
Mostafa Nazari ◽  
...  

AbstractThe aim of this work is to investigate the applicability of radiomic features alone and in combination with clinical information for the prediction of renal cell carcinoma (RCC) patients’ overall survival after partial or radical nephrectomy. Clinical studies of 210 RCC patients from The Cancer Imaging Archive (TCIA) who underwent either partial or radical nephrectomy were included in this study. Regions of interest (ROIs) were manually defined on CT images. A total of 225 radiomic features were extracted and analyzed along with the 59 clinical features. An elastic net penalized Cox regression was used for feature selection. Accelerated failure time (AFT) with the shared frailty model was used to determine the effects of the selected features on the overall survival time. Eleven radiomic and twelve clinical features were selected based on their non-zero coefficients. Tumor grade, tumor malignancy, and pathology t-stage were the most significant predictors of overall survival (OS) among the clinical features (p < 0.002, < 0.02, and < 0.018, respectively). The most significant predictors of OS among the selected radiomic features were flatness, area density, and median (p < 0.02, < 0.02, and < 0.05, respectively). Along with important clinical features, such as tumor heterogeneity and tumor grade, imaging biomarkers such as tumor flatness, area density, and median are significantly correlated with OS of RCC patients.


2017 ◽  
Vol 7 (8) ◽  
pp. 900-917 ◽  
Author(s):  
Yi-Feng Gu ◽  
Shannon Cohn ◽  
Alana Christie ◽  
Tiffani McKenzie ◽  
Nicholas Wolff ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
pp. 18
Author(s):  
Ahmed Nagy ◽  
Mona Kamal ◽  
Hesham El Halawani

Background: Renal cell carcinoma is a rare tumor and till recently few treatment options were available. It is poorly understood why people develop RCC since only a few etiologic factors have been clinically identified as risk factors for RCC.Purpose: To analyze our experience at Ain Shams University Clinical Oncology department in Egypt with patients presenting with advanced renal cell carcinoma to provide a correlations between clinic-pathological factors, treatment and survival outcomes.Methodology: Retrospective review of the data of 54 patients who were diagnosed as RCC and presented to Ain Shams University Clinical Oncology department in Egypt from 1 May 2013 till 1 May 2015. Descriptive and clinic-pathological data were described using simple and relative frequencies. Survival outcome for the patients will be described using Kaplan Meier curves stratified according to morphology, age group and treatment received.Results: The sample included 54 patients (53.7% were males) of whom 14.3% were less than 40 years and 3.7% were elderly (≥ 70 years old). The median age was 55.5 years (SD ± 13.6 , range 19-71). Median PFS was 6.5 months (SD ± 12.3846 Range 43) while the median OS was 13 months (SD ± 12.161 Range 46). PFS in patients aged below 55.5 years was 9 months (95% CI=6.509-11.491) compared to 4 months (95% CI=2.704-5.296) in older patients (p = .004). PFS in patients who achieved PR after sunitinb was 17 months (95% CI=6.916-27.084) compared to 5 months (95% CI=3.699-6.301) in patients who didn’t achieved PR (p < .001). OS in patients aged below 55.5 years was 15 months (95% CI=9.131-20.869) compared to 11 months (95% CI=8.947-13.053) in older patients (p = .012). Favorable pathology status was associated with prolonged OS of 14 months (95% CI= 9.403-18.597) versus 11 months (95% CI=8.363-13.637) for unfavourable pathology status (p = .11). Low grades histopathogy was associated with prolonged OS of 44 months (95% CI= 38.456-49.544) versus 12 months (95% CI=10.077-13.923) for higher grades (p = < .001).Conclusion: Multivariate analyses supported a conclusion that younger age was an independent prognostic factor for survival along with other known risk factors such as tumor grade and pathology status.


2011 ◽  
Vol 29 (2) ◽  
pp. 123-129 ◽  
Author(s):  
Marieta I. Toma ◽  
Thomas Weber ◽  
Matthias Meinhardt ◽  
Stefan Zastrow ◽  
Marc-Oliver Grimm ◽  
...  

2020 ◽  
Vol 19 ◽  
pp. e1957-e1958
Author(s):  
A. Pecoraro ◽  
G. Rosiello ◽  
C. Palumbo ◽  
S. Knipper ◽  
S. Luzzago ◽  
...  

2019 ◽  
Vol 50 (1) ◽  
pp. S10-S11 ◽  
Author(s):  
Nadia Benabdallah ◽  
Catherine Sai-Maurel ◽  
Didier Franck ◽  
Claire de Labriolle-Vaylet ◽  
Aurélie Desbrée ◽  
...  

Author(s):  
Bartlomiej Krazinski ◽  
Anna Kowalczyk ◽  
Agnieszka Sliwinska‑Jewsiewicka ◽  
Jedrzej Grzegrzolka ◽  
Janusz Godlewski ◽  
...  

2020 ◽  
Vol 18 (5) ◽  
pp. e610-e618
Author(s):  
Angela Pecoraro ◽  
Carlotta Palumbo ◽  
Sophie Knipper ◽  
Giuseppe Rosiello ◽  
Stefano Luzzago ◽  
...  

PLoS ONE ◽  
2018 ◽  
Vol 13 (2) ◽  
pp. e0193477 ◽  
Author(s):  
Damien Ambrosetti ◽  
Maeva Dufies ◽  
Bérengère Dadone ◽  
Matthieu Durand ◽  
Delphine Borchiellini ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document